Haqq Christopher bought ELTX
February 2, 2026 · Form 4 insider transaction
Haqq Christopher bought 25,400 shares of Elicio Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,400
Price
$0.00
Total value
N/A
InsiderHaqq Christopher
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 3, 2026
Shares owned after57,381
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer.